MX2019012459A - Composiciones para tratamiento de hiperglucemia en pacientes con diabetes mellitus. - Google Patents
Composiciones para tratamiento de hiperglucemia en pacientes con diabetes mellitus.Info
- Publication number
- MX2019012459A MX2019012459A MX2019012459A MX2019012459A MX2019012459A MX 2019012459 A MX2019012459 A MX 2019012459A MX 2019012459 A MX2019012459 A MX 2019012459A MX 2019012459 A MX2019012459 A MX 2019012459A MX 2019012459 A MX2019012459 A MX 2019012459A
- Authority
- MX
- Mexico
- Prior art keywords
- hyperglycemia
- compositions
- diabetes mellitus
- treatment
- mellitus patients
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 201000001421 hyperglycemia Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000004383 Steviol glycoside Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229930182488 steviol glycoside Natural products 0.000 abstract 1
- 235000019411 steviol glycoside Nutrition 0.000 abstract 1
- 150000008144 steviol glycosides Chemical class 0.000 abstract 1
- 235000019202 steviosides Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporcionan composiciones que comprenden por lo menos un glicósido de esteviol para reducir el nivel de azúcar en la sangre incrementado (hiperglucemia) en pacientes con Diabetes mellitus Tipo 1 y Tipo 2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762486657P | 2017-04-18 | 2017-04-18 | |
PCT/US2018/028140 WO2018195179A1 (en) | 2017-04-18 | 2018-04-18 | Compositions for treatment of hyperglycemia in diabetes mellitus patients |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019012459A true MX2019012459A (es) | 2019-12-19 |
Family
ID=63856877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019012459A MX2019012459A (es) | 2017-04-18 | 2018-04-18 | Composiciones para tratamiento de hiperglucemia en pacientes con diabetes mellitus. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20200069710A1 (es) |
EP (1) | EP3612035A4 (es) |
CN (1) | CN110944521A (es) |
BR (1) | BR112019021858A2 (es) |
MX (1) | MX2019012459A (es) |
PH (1) | PH12019550216A1 (es) |
SG (1) | SG11201909663SA (es) |
WO (1) | WO2018195179A1 (es) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001279593A1 (en) * | 2001-02-01 | 2002-08-12 | Soren Gregersen | A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
US8981081B2 (en) * | 2010-03-12 | 2015-03-17 | Purecircle Usa Inc. | High-purity steviol glycosides |
US20130309389A1 (en) * | 2010-12-13 | 2013-11-21 | Cargill, Incorporated | Glycoside blends |
CN102204611A (zh) * | 2011-03-31 | 2011-10-05 | 遵义陆圣康源科技开发有限责任公司 | 含有机高浓度茶多酚液体饮品 |
ES2579827T3 (es) * | 2011-06-03 | 2016-08-17 | Purecircle Usa | Composición de estevia |
CN103906437A (zh) * | 2011-09-15 | 2014-07-02 | Cj第一制糖株式会社 | 含有可缓慢消化成分的用于减轻糖尿病的甜味剂组合物 |
CN103783615A (zh) * | 2014-02-21 | 2014-05-14 | 郝振东 | 一种降血糖的饮料及其制备方法 |
CN104026446B (zh) * | 2014-05-15 | 2016-08-24 | 广东省农业科学院蚕业与农产品加工研究所 | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 |
CN104687176A (zh) * | 2015-02-10 | 2015-06-10 | 叶节和 | 一种植物饮料及其制备方法 |
CN106359784A (zh) * | 2016-08-30 | 2017-02-01 | 东台纳盛特生物科技有限公司 | 一种以甜菊糖苷为甜味剂的无糖巧克力及其制备方法 |
-
2018
- 2018-04-18 MX MX2019012459A patent/MX2019012459A/es unknown
- 2018-04-18 CN CN201880034724.4A patent/CN110944521A/zh active Pending
- 2018-04-18 SG SG11201909663S patent/SG11201909663SA/en unknown
- 2018-04-18 EP EP18788501.7A patent/EP3612035A4/en not_active Withdrawn
- 2018-04-18 BR BR112019021858-0A patent/BR112019021858A2/pt not_active Application Discontinuation
- 2018-04-18 WO PCT/US2018/028140 patent/WO2018195179A1/en unknown
- 2018-04-18 US US16/605,826 patent/US20200069710A1/en not_active Abandoned
-
2019
- 2019-10-18 PH PH12019550216A patent/PH12019550216A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20200069710A1 (en) | 2020-03-05 |
WO2018195179A1 (en) | 2018-10-25 |
PH12019550216A1 (en) | 2020-09-14 |
SG11201909663SA (en) | 2019-11-28 |
BR112019021858A2 (pt) | 2020-05-26 |
EP3612035A4 (en) | 2021-01-06 |
CN110944521A (zh) | 2020-03-31 |
EP3612035A1 (en) | 2020-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP17073004A (es) | Composiciones farmacéuticas para terapias combinadas | |
PH12018500767A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
MX2013004699A (es) | Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos. | |
MX2017003592A (es) | Sacaridos y mezclas y composiciones de sacaridos. | |
PH12016500762A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
MA33043B1 (fr) | Inhibiteur sglt-2 pour le traitement du diabete sucre de type 1, du diabete sucre de type 2, d'une intolerance au glucose ou d'une hyperglycemie | |
WO2018169282A3 (ko) | Atpif1을 함유하는 당뇨 치료용 약학조성물 | |
PH12019502655A1 (en) | Acylated insulin compound | |
JOP20210201A1 (ar) | مركب لخفض جلوكوز الدم | |
EP4137147A3 (en) | Uses of abaloparatide in reducing fracture risk | |
PH12017501290A1 (en) | Treatment of pediatric type 2 diabetes mellitus patients with lixisenatide | |
CR20220641A (es) | Compuestos de insulina acilada de acción temporal prolongada | |
MX2017006827A (es) | Composiciones inhibidoras. | |
PH12019550216A1 (en) | Compositions for treatment of hyperglycemia in diabetes mellitus patients | |
PH12021550828A1 (en) | Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis | |
PH12020550050A1 (en) | Novel acylated insulin analogues and uses thereof | |
EP3758689A4 (en) | METHODS FOR THE PREVENTION AND TREATMENT OF HYPOGLYCEMIA IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES | |
MX2019014988A (es) | Uso de canagliflozina para reducir o prevenir episodios cardiovasculares en pacientes con diabetes mellitus tipo ii. | |
MX2019013829A (es) | Uso de estracto acuoso de salvia urica epling para regular los niveles de glucosa en sangre para la prevencion y tratamiento de diabetes. | |
JANCIN | Tamoxifen/Anastrozole Sequence Ups Survival | |
MX2021010210A (es) | Una composicion nutricional para usar para mejorar la funcion ejecutiva. | |
MX2008001011A (es) | Formulación auxiliar para el control de niveles altos de glucosa en sangre (hiperglicemia). | |
Alavudeen et al. | An analysis of basal insulin added to dual oral therapy in type 2 diabetes patients | |
PL414618A1 (pl) | Zastosowanie medyczne ekstraktu z ziela Centaurea daghestanica (Lipsky) Wagenitz w leczeniu kardioprotekcyjnym | |
MX2016002865A (es) | Nutracéutico para control del síndrome metabólico. |